Entrada Therapeutics, Inc. (TRDA)
12.58
+0.96
(+8.26%)
USD |
NASDAQ |
Mar 06, 16:00
12.81
+0.23
(+1.83%)
After-Hours: 20:00
Entrada Therapeutics Shareholders Equity (Quarterly) : 306.13M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Plc | 306.11M |
| Repligen Corp. | 2.106B |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Kodiak Sciences, Inc. | 23.69M |
| Arcutis Biotherapeutics, Inc. | 189.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 377.38M |
| Total Liabilities (Quarterly) | 71.24M |
| Debt to Equity Ratio | 0.1664 |
| Current Ratio | 12.53 |
| Net Debt Paydown Yield | 0.53% |